Contributor:

Lejla Vajzovic, MD

4th Duke Fellows Advanced Vitreous Surgery Course

Lejla Vajzovic, MD, Sharon Fekrat, MD, FACS

The 2024 Mentorship Awardee: Lejla Vajzovic, MD

Akshay S. Thomas, MD, MS, and Lejla Vajzovic, MD

Subretinal Injection of tPA

Cindy Cai, MD, Lejla Vajzovic, MD

OCT-A in Pediatric Patients

Lejla Vajzovic, MD

Reinjection Criteria

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

Vasculopathy and ADNIV

Lejla Vajzovic, MD

Retinal Vasculopathy and ADNIV

Lejla Vajzovic, MD

Vitreous Hemorrhage and Full-Thickness Macular Hole

Lejla Vajzovic, MD

Intraoperative OCT for Macular Surgery

Lejla Vajzovic, MD, FASRS; and Ellie Zhou, MD

Spotlight on UNITY® VCS: Experience Extraordinary

Kourous Rezaei, MD; Lejla Vajzovic, MD, FASRS; and Aleksandra V. Rachitskaya, MD, FASRS

How May Tolerance for Subretinal Fluid Change Given Sustained-Release EYP-1901?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

How Can a Multi-MOA Approach Benefit the Management of Wet AMD?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

New Retina Radio Journal Club: OCT Biomarkers in New Onset GA

Yoshihiro Yonekawa, MD; Marion Munk, MD, PhD; Lejla Vajzovic, MD; David Xu, MD

What Evidence Makes EYP-1901 a Promising Treatment for Wet AMD and DME?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD